本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ventyx Biosciences, Inc.

3.57
-0.2900-7.51%
成交量:106.04萬
成交額:385.80萬
市值:2.55億
市盈率:-2.13
高:3.88
開:3.88
低:3.48
收:3.86
52周最高:4.05
52周最低:0.7830
股本:7,130.85萬
流通股本:5,355.59萬
量比:0.75
換手率:1.98%
股息:- -
股息率:- -
每股收益(TTM):-1.6773
每股收益(LYR):-1.9732
淨資產收益率:-48.56%
總資產收益率:-30.23%
市淨率:1.22
市盈率(LYR):-1.81

資料載入中...

2024/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/23

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/30

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/03

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/07

重要事件披露

Form 8-K - Current report
2023/11/22

重要事件披露

Form 8-K - Current report
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/10

重要事件披露

Form 8-K - Current report
2023/10/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities